DYN moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend. In 25 of 29 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 86%.
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on DYN as a result. In 61 of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.
Following a +7.26% 3-day Advance, the price is estimated to grow further. Considering data from situations where DYN advanced for three days, in 237 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
DYN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The 10-day RSI Indicator for DYN moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 29 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 76%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 50-day moving average for DYN moved below the 200-day moving average on October 26, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DYN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for DYN entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.806) is normal, around the industry mean (3.498). P/E Ratio (-5.543) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. DYN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 92 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DYN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The RSI Indicator for PTGX moved out of oversold territory on October 19, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 21 similar instances when the indicator left oversold territory. In 17 of the 21 cases the stock moved higher. This puts the odds of a move higher at 81%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +2.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where PTGX advanced for three days, in 234 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
PTGX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PTGX as a result. In 64 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 68%.
The Moving Average Convergence Divergence Histogram (MACD) for PTGX turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 33 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 65%.
PTGX moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PTGX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
The Aroon Indicator for PTGX entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is 5 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. PTGX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 63 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.153) is normal, around the industry mean (3.498). PTGX has a moderately high P/E Ratio (108.230) as compared to the industry average of (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (34.130) is also within normal values, averaging (440.869).
DYN | PTGX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 40 | 43 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 42 Fair valued | 97 Overvalued | |
PROFIT vs RISK RATING 1..100 | 92 | 5 | |
SMR RATING 1..100 | 98 | 59 | |
PRICE GROWTH RATING 1..100 | 56 | 43 | |
P/E GROWTH RATING 1..100 | 20 | 63 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
DYN's Valuation (42) in the Electric Utilities industry is somewhat better than the same rating for PTGX (97) in the Biotechnology industry. This means that DYN’s stock grew somewhat faster than PTGX’s over the last 12 months.
PTGX's Profit vs Risk Rating (5) in the Biotechnology industry is significantly better than the same rating for DYN (92) in the Electric Utilities industry. This means that PTGX’s stock grew significantly faster than DYN’s over the last 12 months.
PTGX's SMR Rating (59) in the Biotechnology industry is somewhat better than the same rating for DYN (98) in the Electric Utilities industry. This means that PTGX’s stock grew somewhat faster than DYN’s over the last 12 months.
PTGX's Price Growth Rating (43) in the Biotechnology industry is in the same range as DYN (56) in the Electric Utilities industry. This means that PTGX’s stock grew similarly to DYN’s over the last 12 months.
DYN's P/E Growth Rating (20) in the Electric Utilities industry is somewhat better than the same rating for PTGX (63) in the Biotechnology industry. This means that DYN’s stock grew somewhat faster than PTGX’s over the last 12 months.
| DYN | PTGX | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 76% | 1 day ago 81% |
| Stochastic ODDS (%) | 1 day ago 78% | 1 day ago 79% |
| Momentum ODDS (%) | 1 day ago 81% | 1 day ago 68% |
| MACD ODDS (%) | N/A | 1 day ago 65% |
| TrendWeek ODDS (%) | 1 day ago 83% | 1 day ago 75% |
| TrendMonth ODDS (%) | 1 day ago 85% | 1 day ago 82% |
| Advances ODDS (%) | 1 day ago 84% | 6 days ago 76% |
| Declines ODDS (%) | 18 days ago 86% | 4 days ago 76% |
| BollingerBands ODDS (%) | 1 day ago 74% | 1 day ago 77% |
| Aroon ODDS (%) | 1 day ago 79% | 6 days ago 65% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DYN’s FA Score shows that 1 FA rating(s) are green while PTGX’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DYN’s TA Score shows that 4 TA indicator(s) are bullish while PTGX’s TA Score has 4 bullish TA indicator(s).
DYN (@Biotechnology) experienced а +8.27% price change this week, while PTGX (@Biotechnology) price change was -2.49% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +2.97%. For the same industry, the average monthly price growth was -8.33%, and the average quarterly price growth was +85.08%.
DYN is expected to report earnings on Mar 04, 2027.
PTGX is expected to report earnings on Mar 02, 2027.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.
| Ticker / NAME | Correlation To DYN | 1D Price Change % | ||
|---|---|---|---|---|
| DYN | 100% | +3.04% | ||
| RNA - DYN | 64% Loosely correlated | +0.48% | ||
| STOK - DYN | 53% Loosely correlated | +4.41% | ||
| CLDX - DYN | 52% Loosely correlated | +4.59% | ||
| MGTX - DYN | 49% Loosely correlated | +5.44% | ||
| SLDB - DYN | 49% Loosely correlated | +6.53% | ||
More | ||||
A.I.dvisor indicates that over the last year, PTGX has been loosely correlated with MGTX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PTGX jumps, then MGTX could also see price increases.
| Ticker / NAME | Correlation To PTGX | 1D Price Change % | ||
|---|---|---|---|---|
| PTGX | 100% | +2.92% | ||
| MGTX - PTGX | 51% Loosely correlated | +5.44% | ||
| DYN - PTGX | 47% Loosely correlated | +3.04% | ||
| DNTH - PTGX | 47% Loosely correlated | +4.61% | ||
| ARQT - PTGX | 46% Loosely correlated | +2.54% | ||
| IMVT - PTGX | 45% Loosely correlated | +15.13% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RSDE | 24.35 | 0.31 | +1.29% |
| FT Vest U.S. Equity Equal Weight Buffer ETF - December (RSDE) | |||
| NAC | 10.44 | 0.02 | +0.19% |
| Nuveen California Quality Municipal Income Fund | |||
| BSMS | 23.32 | 0.03 | +0.11% |
| Invesco BulletShares 2028 Municipal Bond ETF (BSMS) | |||
| MMCA | 21.39 | 0.02 | +0.10% |
| NYLIM MacKay California Muni Intermediate ETF (MMCA) | |||
| DVDN | 12.78 | N/A | N/A |
| Kingsbarn Dividend Opportunity ETF (DVDN) | |||